Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
Condition(s):Type 2 Diabetes MellitusLast Updated:April 27, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes MellitusLast Updated:April 27, 2023Completed
Condition(s):Obesity; Diabetes Mellitus Type 2Last Updated:June 8, 2016Terminated
Condition(s):Relapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityLast Updated:July 26, 2022Completed
Condition(s):Dermatitis, AtopicLast Updated:June 2, 2020Completed
Condition(s):Dermatitis, AtopicLast Updated:November 21, 2017Completed
Condition(s):Newly Diagnosed; Advanced Ovarian Cancer; FIGO Stage III-IV; BRCA Mutation; Complete Response; Partial Response; First Line Platinum ChemotherapyLast Updated:February 29, 2024Active, not recruiting
Condition(s):Breast CancerLast Updated:November 18, 2014Completed
Condition(s):AsthmaLast Updated:January 14, 2008Completed
Condition(s):Atopic DermatitisLast Updated:March 11, 2020Completed
Condition(s):Chronic InsomniaLast Updated:January 6, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.